From Earlier: D.A. Davidson Reiterates USANA Health Sciences Buy, Raises PT
D.A. Davidson reiterated its USANA Health Sciences (NYSE: USNA) Buy rating and raised its price target from $46 to $51 in a research report published today.
In the report, D.A. Davidson stated, "While North America remains a drag, we are enthusiastic about the business environment and growth opportunities for USANA in Asia. The company ended the quarter with $71 million in cash and no debt."
Shares of USANA Health Sciences closed today at $36.80, up 0.22% from Monday's market close.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.